The role of surgery in the treatment of gastric cancer

Journal of Surgical Oncology

Volumn 101, Issue 8, 2010, Pages 687-692

  Shi, Yingqiang ^a   Zhou, Y E ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; CANCER THERAPY; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; PRIORITY JOURNAL; REOPERATION; REVIEW; STOMACH CANCER;

GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; QUALITY OF LIFE; REOPERATION; STOMACH NEOPLASMS;

EID: 77952982353     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21455     Document Type: Review

References (52)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Verdecchia A, Mariotto A, Gatta G, et al.: Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003;39:1603-1609. (Pubitemid 36829201)
3. Pera M: Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagogastric junction. Recent Results Cancer Res 2000;155:1-14.
4. Sakaguchi T, Watanabe A, Sawada H, et al.: Characteristics and clinical outcome of proximal-third gastric cancer. J Am Coll Surg 1998;187:352-357. (Pubitemid 28467609)
5. Gouzi JL, Huguier M, Fagniez PL, et al.: Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989;209:162-166.
6. Bozzetti F, Marubini E, Bonfanti G, et al.: Subtotal versus total gastrectomy for gastric cancer: Five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170-178.
7. Davies J, Johnston D, Sue-Ling H, et al.: Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg 1998;22:1048-1055. (Pubitemid 28428045)
8. Harrison LE, Karpeh MS, Brennan MF: Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123:127-130. (Pubitemid 28110072)
9. Wagner PK, Ramaswamy A, Ruschoff J, et al.: Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991;78:825-827.
10. Liu C, Lu P, Lu Y, et al.: Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer 2007;7:201-208.
11. Persiani R, Rausei S, Biondi A, et al.: Ratio of metastatic lymph nodes: Impact on staging and survival of gastric cancer. Eur J Surg Oncol 2008;34:519-524. (Pubitemid 351514881)
12. Siewert JR, Bottcher K, Stein HJ, et al.: Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-461. (Pubitemid 30194389)
13. Kodera Y: The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer-Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy. Gastric Cancer 2007;10:69-74.
14. Fatouros M, Ziogas D: Controversy in the treatment of gastric cancer. Ann Surg Oncol 2008;15:1795-1797.
15. Sasagawa T, Solano H, Vega W, et al.: The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: A comparison with surgical results in Japan. Am J Surg 2008;195:53-60. (Pubitemid 350234809)
16. Nakajima T: Gastric cancer treatment guideline in Japan. Gastric Cancer 2002;5:1-5. (Pubitemid 34496345)
17. Bonenkamp JJ, Hermans J, Sasako M, et al.: Extended lymph node dissection for gastric cancer. N Engl J Med 1999;340:908-914. (Pubitemid 29141051)
18. Hartgrink HH, van de Velde CJH, Putter H, et al.: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069-2077. (Pubitemid 41095139)
19. Cuschieri A, Fayers P, Fielding J, et al.: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomized controlled surgical trial. Lancet 1996;347:995-999. (Pubitemid 26112171)
20. Cuschieri A, Weeden S, Fielding J, et al.: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-1530. (Pubitemid 29116815)
21. Bonenkamp JJ, Hermans J, Sasako M, et al.: Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer. Gastric Cancer 1998;1:152-159.
22. Marubini E, Bozzetti F, Miceli R, et al.: Lymphadenectomy in gastric cancer: Prognostic role and therapeutic implications. Eur J Surg Oncol 2002;28:406-412.
23. McCulloch P, Nita ME, Kazi H, et al.: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004;4:CD001964.
24. Parikh D, Johnson M, Chagla L, et al.: D2 gastrectomy: Lessons from a prospective audit of the learning curve. Br J Surg 1996;83:1595-1599. (Pubitemid 26365088)
25. Hartgrink HH, van de Velde CJ: Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-156.
26. Degiuli M, Sasako M, Calgaro M, et al.: Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian gastric cancer study group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004;30:303-308. (Pubitemid 38425649)
27. Edwards P, Blackshaw GR, Lewis WG, et al.: Prospective comparison of D1 vs. modified D2 gastrectomy for carcinoma. Br J Cancer 2004;90:1888-1892. (Pubitemid 38746326)
28. Wu CW, Hsiung CA, Lo SS, et al.: Nodal dissection for patients with gastric cancer: A randomised controlled trial. Lancet Oncol 2006;7:309-315.
29. Yonemura Y, Wu CC, Fukushima N, et al.: Metastasis in paraaortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy. Hepatogastroenterology 2007;54:634-638. (Pubitemid 46724746)
30. Sano T, Sasako M, Yamamoto S, et al.: Gastric cancer surgery morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004;22:2767-2773. (Pubitemid 41079893)
31. Sasako M, Sano T, Yamamoto S, et al.: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-456.
32. Fass J, Schumpelick V: Principles of radical surgery in gastric carcinoma. Hepatogastroenterology 1989;36:13-17. (Pubitemid 19081945)
33. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425. (Pubitemid 17137100)
34. Otsuji E, Yamaguchi T, Sawai K, et al.: Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer 1999;79:1789-1793. (Pubitemid 29132306)
35. Kasakura Y, Fujii M, Mochizuki F, et al.: Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg 2000;179:237-242.
36. Yu W, Choi GS, Chung HY: Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006;93:559-563.
37. Shchepotin IB, Chorny VA, Nauta RJ, et al.: Extended surgical resection in T4 gastric cancer. Am J Surg 1998;175:123-126. (Pubitemid 28132902)
38. Martin RC II, Jaques DP, Brennan MF, et al.: Extended local resection for advanced gastric cancer: Increased survival versus increased morbidity. Ann Surg 2002;236:159-165.
39. Wanebo HJ, Kennedy BJ, Chmiel J, et al.: Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-592.
40. Cho BC, Jeung HC, Choi HJ, et al.: Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single institute. J Surg Oncol 2007;95:461-468.
41. Kim SH, Karpeh MS, Klimstra DS, et al.: Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 1999;3:24-33.
42. Cunningham D, Allum WH, Stenning SP, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
43. Boigé V, Pignon J, Saint-Aubert B, et al.: Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/ cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 2007;25: 18s # 4510.
44. Zhang ZX, Gu XZ, Yin WB, et al.: Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)-report on 370 patients. Int J Radiat Oncol Biol Phys 1998;42:929-934.
45. Fiorica F, Cartei F, Enea M, et al.: The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. Cancer Treat Rev 2007;33:729-740. (Pubitemid 350082668)
46. Lordick F, Ott K, Krause BJ, et al.: PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial. Lancet Oncol 2007;8:797-805. (Pubitemid 47308659)
47. Soetikno R, Kaltenbach T, Yeh R, et al.: Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 2005;23:4490-4498. (Pubitemid 46196578)
48. Brennan MF: Current status of surgery for gastric cancer: A review. Gastric Cancer 2005;8:64-70. (Pubitemid 40655513)
49. Korenaga D, Orita H, Maekawa S, et al.: Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg 1997;84:1563-1566. (Pubitemid 27485533)
50. Yasuda K, Shiraishi N, Suematsu T, et al.: Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma. Cancer 1999;85:2119-2123. (Pubitemid 29215549)
51. Yoshikawa T, Tsuburaya A, Kobayashi O, et al.: Is D2 lymph node dissection necessary for early gastric cancer? Ann Surg Oncol 2002;9:401-405.
52. Hyung WJ, Cheong JH, Kim J, et al.: Application of minimally invasive treatment for early gastric cancer. J Surg Oncol 2004;85:181-185. (Pubitemid 38292820)